During the past decade, Siouxland Regional Cancer Center conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 122 clinical trials were completed, i.e. on average, 249% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 46 clinical trials were completed. i.e. 657.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siouxland Regional Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 110 trials, followed by "Alliance for Clinical Trials in Oncology" with 31 trials sponsored, "SWOG Cancer Research Network" with 26 trials sponsored, "Academic and Community Cancer Research United" with 11 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siouxland Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 96 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 9 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Siouxland Regional Cancer Center" are "Breast Cancer" (12 trials), "Recurrent Breast Carcinoma" (11 trials), "Stage IV Breast Cancer AJCC v6 and v7" (9 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (9 trials) and "Recurrent Squamous Cell Lung Carcinoma" (8 trials). Many other conditions were trialed in "Siouxland Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Siouxland Regional Cancer Center" are "Drug" (195 trials), "Other" (139 trials), "Biological" (90 trials), "Procedure" (34 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (93 trials), "Quality-of-Life Assessment" (41 trials), "Paclitaxel" (28 trials), "Bevacizumab" (24 trials) and "Carboplatin" (22 trials). Other intervention names were less common.

The vast majority of trials in "Siouxland Regional Cancer Center" are 177 trials for "All" genders, 34 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Siouxland Regional Cancer Center". undefined are not yet recruiting, 18 are recruiting, 85 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 98 completed trials in Siouxland Regional Cancer Center, 3 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Siouxland Regional Cancer Center, 15 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Siouxland Regional Cancer Center has several departments that took part in Clinical trials: "Siouxland Hematology Oncology" - 90 trials